Goldman Sachs Group »

Xeris Pharmaceuticals shares owned by Goldman Sachs Group

Quarter-by-quarter ownership of Xeris Pharmaceuticals (XERS) shares owned by Goldman Sachs Group from 13F filings

Historical chart of Goldman Sachs Group investment in Xeris Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xeris Pharmaceuticals held by Goldman Sachs Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xeris Pharmaceuticals by Goldman Sachs Group

Quarter filed Position value Share count Share price at filing
2024-03-31 $556k 251k 2.21
2023-12-31 $608k 259k 2.35
2023-09-30 $247k 133k 1.86
2023-06-30 $587k 224k 2.62
2023-03-31 $203k 125k 1.63
2022-12-31 $218k 164k 1.33
2022-06-30 $173k 113k 1.54
2022-03-31 $1.9M 725k 2.56
2021-12-31 $667k 228k 2.93